Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseThe promise of neuroprotective agents in Parkinson's diseaseRecapitulation of cell signaling events associated with astrogliosis using the brain slice preparationAstrogliosis in CNS pathologies: is there a role for microglia?Corticosterone primes the neuroinflammatory response to DFP in mice: potential animal model of Gulf War IllnessEarly activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicityVascular-directed responses of microglia produced by methamphetamine exposure: indirect evidence that microglia are involved in vascular repair?Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamineModifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumesNeurotoxicity following acute inhalation of aerosols generated during resistance spot weld-bonding of carbon steelSN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylationAge exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the ratMethamphetamine toxicity and messengers of deathMicroglia Ontology and SignalingMechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapyNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityThe ischemic environment drives microglia and macrophage functionGlial modulators as potential treatments of psychostimulant abuseAmphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicitySynergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytesInflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 ExpressionThe combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicityMicroglia-mediated neurotoxicity: uncovering the molecular mechanismsNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineProton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSMicroglia amplify inflammatory activation of astrocytes in manganese neurotoxicity.Role of microglia in a mouse model of paediatric traumatic brain injuryCyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Methamphetamine toxicity and its implications during HIV-1 infection.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesAmphetamine toxicities: classical and emerging mechanisms.A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus.Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous miceRole of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brainInteractions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuseThree-Dimensional Electron Microscopy Reconstruction of Degenerative Dopaminergic Neurons Surrounded by Activated Microglia in Substantia Nigra.Microglial Activation Promotes Cell Survival in Organotypic Cultures of Postnatal Mouse Retinal Explants.Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease
P2860
Q21093232-762C22A7-2D30-4658-87BA-F89725705D20Q21129436-277C67DC-FE5E-4081-A73E-AECDA604766EQ23910808-36F7D510-BA22-4875-AEB6-D619394C8D61Q23911551-46254EF9-68C9-4378-B501-A822C4F7FF9AQ23914342-BFAA97D1-4763-430A-BD65-80FBC5F639DDQ23914345-38E46268-5126-4AE1-9A96-3360E3A90DC1Q23915139-ECF51BE1-FD21-4ECA-8189-DA01AEC52F45Q23916279-B2EBB7DE-817B-4964-A2A6-D2147CAFC1ABQ23916362-6E448D82-AA1E-4595-8935-83697A5D3E8EQ23916371-27090D9A-5A01-4B94-8DC2-9BCA5EC730BFQ23918033-1375F087-CE63-47E1-9CE4-51DDF5A2CA4CQ23923145-67227204-34BC-411B-A5E9-AFC7C8338BB7Q24647617-16AC237E-A528-44E9-8E69-7AB41D7A6B5FQ26742077-5F653DDA-DCAB-49EA-AE87-E652E459A1C1Q26751146-B8F3A557-9F7C-4350-B6F0-E2E272328238Q27027973-CB8D4282-6517-488B-B86C-0139E8BE0BBBQ28086874-63F448E4-EAFA-4E7F-ACF6-5B467B9BA909Q28307030-749D7CBA-8C7E-4B6A-B7C3-100F66C02ABBQ28388234-B0165653-1511-4E69-9457-3D29DD647D70Q28484371-164911EE-280B-44CE-97E1-C56189A83804Q28553963-923A7CCE-353B-471E-B32E-DA2792F3CBC2Q28950585-6BB60266-E299-4444-B374-B922AC22E932Q29547835-CA093A62-FBC2-48CB-9B9B-66F20B7796D8Q30417935-66E62E02-57B3-4BA2-A835-3AE3F274D0B5Q33580220-38384BBA-91DA-499F-AA95-C7C64929FCCEQ33640733-688FBB75-F792-4464-B747-6B6E97A18909Q33718924-792C23F1-EC7F-476F-B2BC-078900933D4FQ33836942-9382540E-4F17-4204-8617-03DAC7657348Q33985461-805F0D2A-BFD7-426E-BB19-0714EDA189D4Q34071942-FFF713C0-AE99-43A3-84A8-B336F8EEB863Q34102002-881D532C-7611-40B5-AA1C-CCB7B31292A3Q34372437-1C5A4726-CF2F-4CB7-9FA3-AE820650DC9FQ34587666-57CED247-B939-4E7C-B699-E96910598660Q34587764-3517FDB9-7111-4973-8A90-35CD36202720Q34954213-D7D5C6C4-D098-4DF1-B137-12F8A550567AQ35007339-7741FF95-8984-4248-B125-81BA111745FAQ35009465-3CD4FCC0-11F1-4DE5-AB54-66E89D06B209Q35674660-C1E26440-4BC1-44F5-9952-412612804DA4Q35739792-10A66C86-2B9E-4147-A14E-C1C8E3E67BA3Q35846770-D5DD355E-D7C3-4270-BD49-88B48E13206E
P2860
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@ast
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en-gb
Minocycline attenuates microgl ...... of tumor necrosis factor-alpha
@nl
type
label
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@ast
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en-gb
Minocycline attenuates microgl ...... of tumor necrosis factor-alpha
@nl
prefLabel
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@ast
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en-gb
Minocycline attenuates microgl ...... of tumor necrosis factor-alpha
@nl
P2860
P921
P3181
P1476
Minocycline attenuates microgl ...... f tumor necrosis factor- alpha
@en
P2093
Krishnan Sriram
P2860
P2880
P304
P3181
P356
10.1111/J.1471-4159.2005.03566.X
P407
P577
2006-02-01T00:00:00Z